Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 2 , Pages 115-116 , March 2011

Prostate cancer: Evidence-based indications for postoperative radiotherapy

References 

  1. Fleshner NE, Evans A, Chadwick K, et al. Clinical significance of the positive surgical margin based upon location, grade, and stage. Urol Oncol. 2010;28:197–204
  2. Collette L, van Poppel H, Bolla M, et al. Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate postoperative irradiation? ((EORTC trial 22911)). Eur J Cancer Nov. 2005;41:2662–2672
  3. Wiegel T, Bottke D, Steiner U, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009;27:2924–2930
  4. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial. J Urol. 2009;181:956–962
  5. Van der Kwast TH, Bolla M, Van Poppel H, et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol. 2007;25:4178–4186
  6. Thompson IM, Tangen CM, Klein EA. Is there a standard of care for pathologic stage T3 prostate cancer?. J Clin Oncol. 2009;27:2898–2899
  7. Trabulsi EJ, Valicenti RK, Hanlon AL, et al. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology. 2008;72:1298–1302discussion 1302–4
  8. Abramowitz MC, Pollack A. Post-prostatectomy radiation therapy for prostate cancer. Semin Radiat Oncol. 2008;18:15–22

PII: S1078-1439(10)00134-1

doi: 10.1016/j.urolonc.2010.05.010

Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 2 , Pages 115-116 , March 2011

Article Tools